Top

Published in:

28-03-2023 | Statins | Original Research

Statin Eligibility and Prescribing Across Racial, Ethnic, and Language Groups over the 2013 ACC/AHA Guideline Change: a Retrospective Cohort Analysis from 2009 to 2018

Authors: John Heintzman , MD MPH, Jorge Kaufmann, ND MS, Carlos J. Rodriguez, MD MPH, Jennifer A. Lucas, PhD, Dave Boston, MD MS, Ayana K. April-Sanders, PhD, Katherine Chung-Bridges, MD, Miguel Marino, PhD

Published in: Journal of General Internal Medicine | Issue 13/2023

Abstract

Background

It is uncertain if the American College of Cardiology/American Heart Association (ACC/AHA) 2013 guidelines for the use of HMGCoA reductase inhibitors (statins) were associated with increased statin eligibility and prescribing across underserved groups.

Objective

To analyze, by race, ethnicity, and preferred language, patients with indications for and presence of a statin prescription before and after the guideline change.

Design

Retrospective cohort study.

Setting

Multistate community health center (CHC) network with linked electronic health records.

Patients

Low-income patients aged ≥ 50 with a primary care visit in 2009–2013 or 2014–2018.

Main Measures

(1) Odds of each race/ethnicity/language group meeting statin eligibility via the National Cholesterol Education Program Adult Treatment Panel III Guidelines in 2009–2013 or the ACC/AHA guidelines in 2014–2018. (2) Among those eligible, odds of each group in each period with a statin prescription.

Key Results

In 2009–2013 (n = 109,330), non-English-preferring Latino (OR = 1.10, 95% CI = 1.03, 1.17), White (OR = 1.41, 95% CI = 1.16, 1.72), and Black patients (OR = 1.25, 95% CI = 1.11, 1.42), were more likely than English-preferring non-Hispanic Whites to meet guideline criteria for statins. Non-English-preferring Black patients, when eligible, were no more likely than non-Hispanic Whites to have statin prescriptions (OR = 1.16, 95% CI = 0.88, 1.54). In 2014–2018 (n = 319,904), English-preferring Latino patients (OR = 1.02, 95% CI = 0.96–1.07) and non-English-preferring Black patients (OR = 1.08, 95% CI = 0.98, 1.19) had similar odds of statin prescription to English-preferring non-Hispanic White patients. English-preferring Black patients were less likely (OR = 0.95, 95% CI = 0.91–0.99) to have a prescription than English-preferring non-Hispanic Whites.

Conclusion

Across the 2013 ACC/AHA guideline change in CHCs serving low-income patients, non-English-preferring patients were consistently more likely to be eligible for and have been prescribed statins. English-preferring Latino and English-preferring Black patients experienced reduced prescribing, comparatively, after the guideline change. Further work should explore the contextual factors that may influence guideline effectiveness and care equity.

Available only for authorised users

Centers for Disease Control and Prevention. Leading Causes of Death- Hispanic Males- United States 2016 2019 [cited 2022 July 22]. Available from: https://www.cdc.gov/healthequity/lcod/men/2016/hispanic/index.htm#anchor_1571145330.

Centers for Disease Control and Prevention. Leading Cause of Death-Hispanics Females 2017 2019 [cited 2021 February 10].

An J, Zhang Y, Muntner P, Moran AE, Hsu JW, Reynolds K. Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status. J Am Heart Assoc. 2020;9(23):e017310. https://doi.org/10.1161/JAHA.120.017310.CrossRefPubMedPubMedCentral

Dupre ME, Gu D, Xu H, Willis J, Curtis LH, Peterson ED. Racial and Ethnic Differences in Trajectories of Hospitalization in US Men and Women With Heart Failure. J Am Heart Assoc. 2017;6(11). https://doi.org/10.1161/JAHA.117.006290.CrossRefPubMedPubMedCentral

Eapen ZJ, Liang L, Shubrook JH, Bauman MA, Bufalino VJ, Bhatt DL, et al. Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage. Am Heart J. 2014;168(3):398-404. https://doi.org/10.1016/j.ahj.2014.06.007.CrossRefPubMed

Daviglus ML, Pirzada A, Durazo-Arvizu R, Chen J, Allison M, Avilés-Santa L, et al. Prevalence of Low Cardiovascular Risk Profile Among Diverse Hispanic/Latino Adults in the United States by Age, Sex, and Level of Acculturation: The Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc. 2016;5(8). https://doi.org/10.1161/JAHA.116.003929.CrossRefPubMedPubMedCentral

Casagrande SS, Aviles-Santa L, Corsino L, Daviglus ML, Gallo LC, Espinoza Giacinto RA, et al. Hemoglobin A1C, Blood Pressure, and LDL-Cholesterol Control Among Hispanic/Latino Adults with Diabetes: Results from the Hispanic Community Health Study/study of Latinos (HCHS/SOL). Endocr Pract. 2017;23(10):1232-53. https://doi.org/10.4158/EP171765.OR.CrossRefPubMedPubMedCentral

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934. https://doi.org/10.1016/j.jacc.2013.11.002.CrossRefPubMed

Adedinsewo D, Taka N, Agasthi P, Sachdeva R, Rust G, Onwuanyi A. Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012. Clin Cardiol. 2016;39(9):491-6. https://doi.org/10.1002/clc.22577.CrossRefPubMedPubMedCentral

10.

Qato DM, Lee TA, Durazo-Arvizu R, Wu D, Wilder J, Reina SA, et al. Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc. 2016;5(4):e002905. https://doi.org/10.1161/JAHA.115.002905.CrossRefPubMedPubMedCentral

11.

Pauff BR, Jiroutek MR, Holland MA, Sutton BS. Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010. Clin Ther. 2015;37(6):1329-39. https://doi.org/10.1016/j.clinthera.2015.03.020.CrossRefPubMed

12.

Johansen ME, Hefner JL, Foraker RE. Antiplatelet and Statin Use in US Patients With Coronary Artery Disease Categorized by Race/Ethnicity and Gender, 2003 to 2012. Am J Cardiol. 2015;115(11):1507-12. https://doi.org/10.1016/j.amjcard.2015.02.052.CrossRefPubMed

13.

Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation. 2014;129(7):754-63. https://doi.org/10.1161/CIRCULATIONAHA.113.002658.CrossRefPubMed

14.

Heintzman JD, Bailey SR, Muench J, Killerby M, Cowburn S, Marino M. Lack of Lipid Screening Disparities in Obese Latino Adults at Health Centers. Am J Prev Med. 2017;52(6):805-9. https://doi.org/10.1016/j.amepre.2016.12.020.CrossRefPubMedPubMedCentral

15.

Gu A, Kamat S, Argulian E. Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014. Diabetes Res Clin Pract. 2018;139:1-10. https://doi.org/10.1016/j.diabres.2018.02.019.CrossRefPubMed

16.

Jurkowski JM. Nativity and cardiovascular disease screening practices. J Immigr Minor Health. 2006;8(4):339-46. https://doi.org/10.1007/s10903-006-9004-z.CrossRefPubMed

17.

Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Perreira KM, Calip GS, Nutescu EA, et al. Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017). Am J Public Health. 2020;110(9):1397-404. https://doi.org/10.2105/AJPH.2020.305745.CrossRefPubMedPubMedCentral

18.

Eamranond PP, Wee CC, Legedza AT, Marcantonio ER, Leveille SG. Acculturation and cardiovascular risk factor control among Hispanic adults in the United States. Public Health Rep. 2009;124(6):818-24. https://doi.org/10.1177/003335490912400609.CrossRefPubMedPubMedCentral

19.

López-Cevallos DF, Escutia G, González-Peña Y, Garside LI. Cardiovascular disease risk factors among Latino farmworkers in Oregon. Ann Epidemiol. 2019;40:8-12.e1. https://doi.org/10.1016/j.annepidem.2019.10.002.CrossRefPubMed

20.

Bailey SR, Hwang J, Marino M, Quiñones AR, Lucas JA, Chan BL, et al. Smoking-Cessation Assistance Among Older Adults by Ethnicity/Language Preference. Am J Prev Med. 2022;63(3):423-30. https://doi.org/10.1016/j.amepre.2022.03.024.CrossRefPubMedPubMedCentral

21.

Heintzman J, Bailey SR, Cowburn S, Dexter E, Carroll J, Marino M. Pneumococcal Vaccination in Low-Income Latinos: An Unexpected Trend in Oregon Community Health Centers. J Health Care Poor Underserved. 2016;27(4):1733-44. https://doi.org/10.1353/hpu.2016.0159.CrossRefPubMed

22.

Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato DM. Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016. J Am Pharm Assoc (2003). 2021;61(4):e263-e78. https://doi.org/10.1016/j.japh.2021.01.032.CrossRefPubMed

23.

National Cholesterol Education Program (NCEP) Expert Panel on Detection Ea, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.CrossRef

24.

Qureshi WT, Kaplan RC, Swett K, Burke G, Daviglus M, Jung M, et al. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Am Heart Assoc. 2017;6(5). https://doi.org/10.1161/JAHA.116.005045.CrossRefPubMedPubMedCentral

25.

National Association of Community Health Centers. Community Health Center Chartbook 2020. 2020. https://www.nachc.org/wp-content/uploads/2020/01/Chartbook-2020-Final.pdf. Accessed 1 Jun 2022.

26.

Kaufmann J, Marino M, Lucas JA, Rodriguez CJ, Bailey SR, April-Sanders AK, et al. Racial, ethnic, and language differences in screening measures for statin therapy following a major guideline change. Prev Med. 2022;164:107338. https://doi.org/10.1016/j.ypmed.2022.107338.CrossRefPubMed

27.

Wójcik C, Shapiro MD. Translating AHA/ACC cholesterol guidelines into meaningful risk reduction. J Fam Pract. 2019;68(4):206;10;12;14;17;21B.

28.

Lowenstern A, Li S, Navar AM, Virani S, Lee LV, Louie MJ, et al. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2018;200:118-24. https://doi.org/10.1016/j.ahj.2018.03.011.CrossRefPubMedPubMedCentral

29.

Levy ME, Greenberg AE, Magnus M, Younes N, Castel A. Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients. AIDS Patient Care STDS. 2018;32(2):58-69. https://doi.org/10.1089/apc.2017.0304.CrossRefPubMedPubMedCentral

30.

Bucheit JD, Helsing H, Nadpara P, Virani SS, Dixon DL. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. J Clin Lipidol. 2018;12(2):367-74.e3. https://doi.org/10.1016/j.jacl.2017.11.010.CrossRefPubMed

31.

Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines. JAMA. 2017;317(15):1563-7. https://doi.org/10.1001/jama.2017.3416.CrossRefPubMedPubMedCentral

32.

Hong JC, Blankstein R, Shaw LJ, Padula WV, Arrieta A, Fialkow JA, et al. Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. JACC Cardiovasc Imaging. 2017;10(8):938-52. https://doi.org/10.1016/j.jcmg.2017.04.014.CrossRefPubMed

33.

Phan BAP, Weigel B, Ma Y, Scherzer R, Li D, Hur S, et al. Utility of 2013 American College of Cardiology/American Heart Association cholesterol guidelines in HIV-infected adults with carotid atherosclerosis. Circ Cardiovasc Imaging. 2017;10(7). https://doi.org/10.1161/CIRCIMAGING.116.005995.

34.

Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, et al. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. J Am Heart Assoc. 2017;6(7). https://doi.org/10.1161/JAHA.117.005627.CrossRefPubMedPubMedCentral

35.

Housholder-Hughes SD, Martin MM, McFarland MR, Creech CJ, Shea MJ. Healthcare provider compliance with the 2013 ACC/AHA Adult Cholesterol Guideline recommendation for high-intensity dose statins for patients with coronary artery disease. Heart Lung. 2017;46(4):328-33. https://doi.org/10.1016/j.hrtlng.2017.03.005.CrossRefPubMed

36.

Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017;2(4):361-9. https://doi.org/10.1001/jamacardio.2016.5922.CrossRefPubMedPubMedCentral

37.

Valentino M, Al Danaf J, Panakos A, Ragupathi L, Duffy D, Whellan D. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke. Am Heart J. 2016;181:130-6. https://doi.org/10.1016/j.ahj.2016.07.024.CrossRefPubMed

38.

Jamé S, Wittenberg E, Potter MB, Fleischmann KE. The new lipid guidelines: what do primary care clinicians think? Am J Med. 2015;128(8):914.e5-.e10. https://doi.org/10.1016/j.amjmed.2015.02.013.CrossRefPubMedCentral

39.

Hayward RA. Should family physicians follow the new ACC/AHA cholesterol treatment guideline? Not completely: why it is right to drop LDL-C targets but wrong to recommend statins at a 7.5% 10-year risk. Am Fam Physician. 2014;90(4):223-4.PubMed

40.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145(8):e153-e639. https://doi.org/10.1161/CIR.0000000000001052.CrossRefPubMed

41.

Rana JS, Tabada GH, Solomon MD, Lo JC, Jaffe MG, Sung SH, et al. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016;67(18):2118-30. https://doi.org/10.1016/j.jacc.2016.02.055.CrossRefPubMedPubMedCentral

42.

Rodriguez F, Chung S, Blum MR, Coulet A, Basu S, Palaniappan LP. Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records. J Am Heart Assoc. 2019;8(14):e011874. https://doi.org/10.1161/JAHA.118.011874.CrossRefPubMedPubMedCentral

43.

Muntner P, Colantonio LD, Cushman M, Goff DC, Howard G, Howard VJ, et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311(14):1406-15. https://doi.org/10.1001/jama.2014.2630.CrossRefPubMedPubMedCentral

44.

Arcia E, Skinner M, Bailey D, Correa V. Models of acculturation and health behaviors among Latino immigrants to the US. Soc Sci Med. 2001;53(1):41-53. https://doi.org/10.1016/s0277-9536(00)00310-5.CrossRefPubMed

45.

Adam MB, McGuire JK, Walsh M, Basta J, LeCroy C. Acculturation as a predictor of the onset of sexual intercourse among Hispanic and white teens. Arch Pediatr Adolesc Med. 2005;159(3):261-5. https://doi.org/10.1001/archpedi.159.3.261.CrossRefPubMed

46.

Abraído-Lanza AF, Chao MT, Flórez KR. Do healthy behaviors decline with greater acculturation? Implications for the Latino mortality paradox. Soc Sci Med. 2005;61(6):1243-55. https://doi.org/10.1016/j.socscimed.2005.01.016.CrossRefPubMedPubMedCentral

47.

Norris P, Ng LF, Kershaw V, Hanna F, Wong A, Talekar M, et al. Knowledge and reported use of antibiotics amongst immigrant ethnic groups in New Zealand. J Immigr Minor Health. 2010;12(1):107-12. https://doi.org/10.1007/s10903-008-9224-5.CrossRefPubMed

48.

Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis. 2001;11(3):496-518.PubMed

49.

Heintzman J, Kaufmann J, Lucas J, Suglia S, Garg A, Puro J, et al. Asthma Care Quality, Language, and Ethnicity in a Multi-State Network of Low-Income Children. J Am Board Fam Med. 2020;33(5):707-15. https://doi.org/10.3122/jabfm.2020.05.190468.CrossRefPubMedPubMedCentral

50.

Heintzman J, Hwang J, Quiñones AR, Guzman CEV, Bailey SR, Lucas J, et al. Influenza and pneumococcal vaccination delivery in older Hispanic populations in the United States. J Am Geriatr Soc. 2021. https://doi.org/10.1111/jgs.17589.CrossRefPubMedPubMedCentral

51.

Dorsch MP, Lester CA, Ding Y, Joseph M, Brook RD. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System. J Am Heart Assoc. 2019;8(22):e014709. https://doi.org/10.1161/JAHA.119.014709.CrossRefPubMedPubMedCentral

52.

Fairman KA, Romanet D, Early NK, Goodlet KJ. Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms. J Cardiovasc Pharmacol Ther. 2020;25(1):27-36. https://doi.org/10.1177/1074248419866153.CrossRefPubMed

53.

Flores G, Tomany-Korman SC. Racial and ethnic disparities in medical and dental health, access to care, and use of services in US children. Pediatrics. 2008;121(2):e286-98. https://doi.org/10.1542/peds.2007-1243.CrossRefPubMed

54.

Ferdinand KC, Yadav K, Nasser SA, Clayton-Jeter HD, Lewin J, Cryer DR, et al. Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence. J Clin Hypertens (Greenwich). 2017;19(10):1015-24. https://doi.org/10.1111/jch.13089.CrossRefPubMed

55.

Ayanian JZ, Landon BE, Newhouse JP, Zaslavsky AM. Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med. 2014;371(24):2288-97. https://doi.org/10.1056/NEJMsa1407273.CrossRefPubMedPubMedCentral

56.

Bey GS, Person SD, Kiefe C. Gendered Race and Setting Matter: Sources of Complexity in the Relationships Between Reported Interpersonal Discrimination and Cardiovascular Health in the CARDIA Study. J Racial Ethn Health Disparities. 2020;7(4):687-97. https://doi.org/10.1007/s40615-020-00699-6.CrossRefPubMedPubMedCentral

57.

Saha S, Komaromy M, Koepsell TD, Bindman AB. Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med. 1999;159(9):997-1004. https://doi.org/10.1001/archinte.159.9.997.CrossRefPubMed

58.

Forde AT, Sims M, Muntner P, Lewis T, Onwuka A, Moore K, et al. Discrimination and Hypertension Risk Among African Americans in the Jackson Heart Study. Hypertension. 2020;76(3):715-23. https://doi.org/10.1161/HYPERTENSIONAHA.119.14492.CrossRefPubMed

59.

Reverby SM. The Milbank Memorial Fund and the US Public Health Service Study of Untreated Syphilis in Tuskegee: A Short Historical Reassessment. Milbank Q. 2022;100(2):327-40. https://doi.org/10.1111/1468-0009.12574.CrossRefPubMedPubMedCentral

Title: Statin Eligibility and Prescribing Across Racial, Ethnic, and Language Groups over the 2013 ACC/AHA Guideline Change: a Retrospective Cohort Analysis from 2009 to 2018
Authors: John Heintzman , MD MPH
Jorge Kaufmann, ND MS
Carlos J. Rodriguez, MD MPH
Jennifer A. Lucas, PhD
Dave Boston, MD MS
Ayana K. April-Sanders, PhD
Katherine Chung-Bridges, MD
Miguel Marino, PhD
Publication date: 28-03-2023
Publisher: Springer International Publishing
Keyword: Statins
Published in: Journal of General Internal Medicine / Issue 13/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-023-08139-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Design

Setting

Patients

Main Measures

Key Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 13/2023

Association of Hospital Discharge Against Medical Advice and Coded Housing Instability in the US

Reducing Disparities in No Show Rates Using Predictive Model-Driven Live Appointment Reminders for At-Risk Patients: a Randomized Controlled Quality Improvement Initiative

Skin Changes of POEMS

Estimating the Primary Care Workforce for Medicare Beneficiaries Using an Activity-Based Approach

Racial-Ethnic Composition of Primary Care Practices and Comprehensive Primary Care Plus Initiative Participation

Caregiver Experience of Tele-dementia Care for Older Veterans

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage